Double Medical(SZ:002901) Xin Lang Cai Jing·2025-09-30 06:17Group 1 - The core viewpoint of the news is that Dabo Medical has seen a stock price increase of 5.02%, reaching 56.11 CNY per share, with a total market capitalization of 23.231 billion CNY [1] - Dabo Medical, established on August 12, 2004, and listed on September 22, 2017, specializes in the production, research, and sales of high-value medical consumables [1] - The revenue composition of Dabo Medical includes trauma products (38.68%), spinal products (17.95%), minimally invasive surgical products (16.34%), joint products (10.37%), other products (9.27%), neurosurgical products (4.50%), and dental products (2.89%) [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Dabo Medical, having increased its holdings by 141,900 shares in the second quarter, totaling 756,800 shares, which represents 0.26% of the circulating shares [2] - The Southern CSI 1000 ETF has achieved a year-to-date return of 27.27% and a one-year return of 47.41%, ranking 2099 out of 4220 and 1424 out of 3846 respectively [2] - The fund manager, Cui Lei, has been in charge for 6 years and 329 days, with the fund's total asset size at 94.976 billion CNY and a best return of 145.53% during the tenure [3]